HI SB541

Simplifies the definition of "manufactured cannabis product" in Hawaii Revised Statutes section 329D-1 by replacing a specific list with a reference to department-specified products.

Changes "transdermal patches" to "transdermal devices as approved by the department" to include non-patch delivery devices that administer cannabis through the skin.

Establishes a numbered list of eight specific product types (capsules, lozenges, pills, oils and oil extracts, tinctures, ointments and skin lotions, transdermal devices, and pre-filled sealed containers) plus a category for other department-specified products.

Adds detailed requirements for devices that provide safe pulmonary administration, including specifications for heating elements, tamper-resistant containers, temperature control to prevent combustion, and use of inert materials.

Takes effect on July 1, 2050.